Jeffrey B Kindler sold $855K of Precigen (PGEN)

Executed Dec 12 2025, disclosed Dec 16 2025, 4 days later.

Value, as filed

$855K

235,467 sh × $3.63

Executed

Dec 12 2025

the trade date, as filed

Disclosed

Dec 16 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jeffrey B Kindler Director profile →

Jeffrey B Kindler (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Precigen, Inc. (PGEN). The largest single filing was $1.4M of PGEN (185,000 sh × $7.44, as filed), executed Aug 26.

The name

PGEN

Precigen, Inc. PGEN · Healthcare · 21 filings in 24 months ticker →

Healthcare · Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to tar…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jeffrey B Kindler in PGEN

PGENSALE Precigen, Inc. $1.4M
185,000 sh × $7.44
Exec Aug 26
Filed Aug 28 · 8:39 PM ET PGENSALE Precigen, Inc. $604K
174,360 sh across 2 lots
Exec Sep 29 2025
Filed Oct 1 2025 · 5:30 PM ET